MIRM
Mirum Pharmaceuticals Inc
86.00$
+5.7%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -125.0% | – | -227.2% | – | – | +229.6% | -84.7% | -3,870.6% | – | – | |
| – | +106.4% | +3.1% | +3.4% | +3.4% | +0.0% | -0.1% | +0.1% | +0.1% | +0.2% | +13.2% | +0.9% | – | |
| – | +15.9% | +17.8% | +3.4% | +0.6% | +11.3% | +19.3% | +16.9% | -1.8% | +5.0% | +90.3% | +84.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -93.5% | -178.8% | – | – | – | – | -215.3% | – | -39.3% | – | |
| – | – | -99.7% | +82,815.4% | -5.5% | -99.8% | +105.0% | +207.3% | +48.4% | +220.9% | +10.7% | +3.5% | – | |
| – | -98.9% | -99.4% | +559,261.5% | -75.2% | – | -2,617.0% | -59.1% | -66.3% | – | -1,250.0% | +1,382.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.1% | -32.2% | +505.1% | -47.0% | +38.2% | +19.1% | +36.6% | +85.3% | -44.1% | +2,901.2% | +78.3% | – | |
| – | -387.0% | – | -519.9% | – | – | – | – | +229.6% | -70.9% | +80.2% | +21.5% | – | |
| – | – | – | -195.9% | – | – | – | – | +231.5% | -86.2% | -4,296.6% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.